ZimVie Concludes Public Trading Chapter Following ARCHIMED Acquisition

The curtain has fallen on ZimVie Inc.'s tenure as a publicly traded entity. The dental implant manufacturer concluded its final trading session on October 20, 2025, completing its acquisition by healthcare-focused investment firm ARCHIMED. The company has subsequently been delisted from public exchanges.

ARCHIMED secured all outstanding ZimVie shares at a price of $19 per share, valuing the comprehensive acquisition at approximately $730 million. The deal received overwhelming shareholder support through an early October vote that saw investors firmly back the transaction.

This acquisition concludes a relatively brief period of public market presence for ZimVie, which initially launched as a spin-off from Zimmer Biomet in 2022. The transition to private ownership under ARCHIMED signals a fundamental restructuring of the company's operational framework.

Should investors sell immediately? Or is it worth buying ZimVie?

Strategic Shift to Private Ownership

ARCHIMED, a specialized investment entity concentrating exclusively on healthcare sectors, intends to accelerate ZimVie's expansion initiatives and reinforce its international standing within the competitive dental implant market. This strategic move follows ZimVie's earlier divestiture of its spine business to H.I.G. Capital, a measure originally implemented to address investor concerns regarding operational synergies and debt management.

Implications for Former Investors

For shareholders, the final significant action was the disbursement of $19 for each share held. Following the public announcement of the acquisition terms, ZimVie formally withdrew its financial guidance for fiscal year 2025.

The company now operates beyond the regulatory scope of public markets, liberated from quarterly performance pressures and mandatory public disclosure requirements. ZimVie's future trajectory rests entirely under ARCHIMED's strategic direction as it navigates the healthcare landscape as a privately held enterprise.